STeroids to REduce Systemic Inflammation After Infant Heart Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

1,263

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Congenital Heart Disease in ChildrenInflammatory Response
Interventions
DRUG

Methylprednisolone

IV Steroid pre-operative and intra-operative

DRUG

Isotonic saline

Isotonic saline pre-operative and intra-operative

Trial Locations (23)

14642

University of Rochester Medical Center, Rochester

15224

Children's Hospital of Pittsburgh, Pittsburgh

21205

Johns Hopkins University, Baltimore

27710

Duke University Medical Center, Durham

29425

Medical University of South Carolina, Charleston

32608

University of Florida Health - Shands Hospital, Gainesville

37232

Vanderbilt University Medical Center, Nashville

43205

Nationwide Children's Hospital, Columbus

44195

Cleveland Clinic, Cleveland

53226

Medical College of Wisconsin, Milwaukee

55404

Children's Hospital and Clinics of Minnesota, Minneapolis

60453

Advocate Children's Hospital, Oak Lawn

63110

St. Louis Children's Hospital, St Louis

64108

Children's Mercy Hospital, Kansas City

68114

Children's Hospital and Medical Center, Omaha

77030

Baylor College of Medicine, Texas Children's Hospital, Houston

80045

University of Colorado, Denver, Aurora

84113

Utah/Primary Children's Medical Center, Salt Lake City

90027

Children's Hospital of Los Angeles, Los Angeles

60611-2605

Ann & Robert Lurie Children's Hospital of Chicago, Chicago

10032-3702

Morgan Stanley Children's Hospital of New York Presbyterian, New York

45229-3039

Children's Hospital Medical Center, Cincinnati

75390-9020

The University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Kevin Hill

OTHER

NCT03229538 - STeroids to REduce Systemic Inflammation After Infant Heart Surgery | Biotech Hunter | Biotech Hunter